A Study of the Effects of Itraconazole or Carbamazepine on LY3537982 in Healthy Participants
Status:
Recruiting
Trial end date:
2023-08-17
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate the effect of itraconazole and carbamazepine on
LY3537982 when administered as multiple doses by conducting the blood tests to measure how
much LY3537982 is in the bloodstream and how the body handles and eliminates LY3537982 in
adult healthy participants. The study will also evaluate the safety and tolerability of
LY3537982. The study is conducted in two parts. Participants will stay in the research center
during the study, which will last about 11 and 15 days for part 1 and part 2, respectively,
not including screening.